SIPA1L2

SIPA1L2 (SPAR2) is a RapGAP protein that catalyzes GTP hydrolysis on Rap1 and Rap2, functioning as a negative regulator of Rap signaling in neurons and other cell types (PMID:17961154, PMID:35922833). In hippocampal presynaptic terminals, SIPA1L2 connects TrkB-containing amphisomes to the dynein retrograde transport machinery, with its RapGAP activity regulated by the autophagosomal protein LC3; loss of Sipa1l2 in mice impairs BDNF-dependent presynaptic plasticity (PMID:31784514). In peripheral nerve, SIPA1L2 participates in a SOX10-regulated myelination gene network, binds β-actin and MYH9, and modulates PMP22 expression and cholesterol biosynthesis pathways, acting as a genetic modifier of the CMT1A demyelinating neuropathy phenotype (PMID:30706531, PMID:38472136).

1. 2007 High

   Establishing SIPA1L2 as a functional RapGAP answered the basic question of enzymatic identity: SIPA1L2 catalyzes GTP hydrolysis on both Rap1 and Rap2, is enriched at synapses, and interacts with the scaffolding protein ProSAPiP, distinguishing it from its paralog SPAR1.

   Evidence In vitro GAP assay, synaptosome/PSD fractionation, co-IP, and overexpression in cultured hippocampal neurons

   PMID:17961154

   Open questions at the time

   • Endogenous substrates and in vivo Rap specificity not determined
   • Functional consequence of ProSAPiP interaction at synapses unknown
   • No loss-of-function data to assess requirement in neurons
2. 2016 Low

   Expression profiling in Xenopus embryos revealed maternally supplied sipa1l2 mRNA with enrichment in branchial arches, glomerulus, and eye, suggesting developmental roles beyond the nervous system.

   Evidence RT-PCR and whole-mount in situ hybridization in Xenopus laevis embryos

   PMID:27384056

   Open questions at the time

   • No functional or loss-of-function data in Xenopus — expression only
   • Relevance to mammalian non-neuronal tissues not tested
   • No mechanistic link to RapGAP activity in these tissues
3. 2019 High

   The key mechanistic advance was demonstrating how SIPA1L2 couples neurotrophin signaling to retrograde transport: SIPA1L2 links TrkB-containing amphisomes to dynein at presynaptic boutons, with LC3 regulating its RapGAP activity; knockout mice showed impaired BDNF-dependent presynaptic plasticity, establishing an in vivo requirement.

   Evidence Co-IP, live imaging of retrograde transport, Sipa1l2 knockout mouse with synaptic plasticity assays

   PMID:31784514

   Open questions at the time

   • Structural basis of LC3–SIPA1L2 interaction and how LC3 modulates GAP activity unresolved
   • Whether the amphisome-dynein coupling function extends to other neurotrophin receptors unknown
   • Postsynaptic roles of SIPA1L2 not addressed
4. 2019 Medium

   Identification of SIPA1L2 as a genetic modifier of CMT1A severity established a peripheral nerve function: SIPA1L2 binds β-actin and MYH9, operates within a SOX10-regulated myelination network, and its knockdown reduces PMP22 expression in Schwannoma cells.

   Evidence GWAS, co-IP with mass spectrometry validation, ChIP, siRNA knockdown in Schwannoma cells

   PMID:30706531

   Open questions at the time

   • Modifier effect identified in a single cohort — replication in independent CMT1A populations needed
   • Direct mechanism linking SIPA1L2 RapGAP activity to PMP22 regulation not established
   • Whether β-actin/MYH9 binding is required for the myelination phenotype untested
5. 2022 Medium

   Parallel studies in non-neuronal contexts showed SIPA1L2 negatively regulates autophagy in ox-LDL-treated endothelial cells and acts as a negative regulator of Rap1/PI3K/AKT during chondrogenic differentiation, broadening its functional scope beyond neurons.

   Evidence Dual-luciferase 3ʹ-UTR reporter assay, autophagic flux assay with siRNA knockdown (endothelial cells); miRNA mimic/inhibitor and overexpression in mesenchymal stem cell chondrogenesis

   PMID:35279183 PMID:35922833

   Open questions at the time

   • Direct RapGAP activity not measured in either non-neuronal system
   • Whether SIPA1L2 autophagy regulation in endothelial cells uses the same LC3-dependent mechanism as in neurons is unknown
   • Each finding from a single laboratory
6. 2024 Medium

   Genetic epistasis in mice validated the CMT1A modifier role: Sipa1l2 deletion in the C3-PMP22 model preserved neuromuscular function and altered myelin thickness, implicating the cholesterol biosynthesis pathway as a downstream effector.

   Evidence Sipa1l2 exon-1 knockout crossed to C3-PMP22 transgenic mice; wire-hang endurance, nerve morphometrics, gene expression profiling

   PMID:38472136

   Open questions at the time

   • Cholesterol biosynthesis link is transcriptomic — direct metabolic measurements not reported
   • Mechanism connecting SIPA1L2 RapGAP activity to cholesterol pathway regulation unclear
   • Whether Sipa1l2 deletion affects myelination independently of the PMP22 overexpression background not tested

• A unifying structural and mechanistic model explaining how SIPA1L2's RapGAP domain, actin-binding domain, and LC3-interacting region coordinate its dual roles in presynaptic amphisome transport and peripheral myelination remains to be established.
• No crystal structure or cryo-EM data for any SIPA1L2 domain
• Relative contributions of Rap1 vs Rap2 GTPase regulation in each tissue context unknown
• Whether LC3-mediated regulation of RapGAP activity operates in Schwann cells or other non-neuronal contexts untested